Page 13 - Protein Sciences News Today

SG Americas Securities LLC raised its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 340.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,533 shares of the biotechnology company’s stock after purchasing an additional 16,647 […]

StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a hold rating to a buy rating in a research report report published on Monday. TECH has been the subject of several other reports. Benchmark restated a buy rating and issued a $120.00 target price on shares of Bio-Techne in a research report on Friday, […]

StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a hold rating to a buy rating in a research note released on Monday. Other analysts have also issued research reports about the company. Wells Fargo & Company raised Bio-Techne from an underweight rating to an equal weight rating and set a $90.00 price objective […]

New Mexico Educational Retirement Board grew its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 275.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 7,500 shares of the biotechnology company’s stock after acquiring an additional 5,500 shares during the quarter. New Mexico Educational Retirement Board’s holdings in Bio-Techne were […]

BOK Financial Private Wealth Inc. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,200 shares of the biotechnology company’s stock after purchasing an additional 2,400 shares during the quarter. BOK Financial Private […]

Bio-Techne Co. (NASDAQ:TECH – Get Rating) has earned an average rating of “Moderate Buy” from the twelve brokerages that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month target price among brokerages that […]

National Bank of Canada FI raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 3,001.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,621 shares of the biotechnology company’s stock after purchasing an additional 4,472 shares during the […]

Investing in vaccine manufacturing has both economic and societal benefits, in addition to protecting human health and limiting infection spread.

New York State Teachers Retirement System lifted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 299.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 192,940 shares of the biotechnology company’s stock after buying an additional 144,691 shares during the period. New York State Teachers Retirement System’s holdings in Bio-Techne […]

Ellis Investment Partners LLC raised its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,416 shares of the biotechnology company’s stock after purchasing an additional 1,812 shares during the quarter. Ellis […]